California State Board of Pharmacy 1625 N. Market Blvd, N219, Sacramento, CA 95834 Phone: (916) 574-7900 Fax: (916) 574-8618 www.pharmacy.ca.gov
STATE AND CONSUMER SERVICES AGENCY
DEPARTMENT OF CONSUMER AFFAIRS
GOVERNOR EDMUND G. BROWN JR.
Page 1 of 2 Meeting Materials will be available on the board’s Web site at www.pharmacy.ca.gov by March 18, 2013
NOTICE OF MEETING AND AGENDA
Compounding Subcommittee
March 19, 2013
Contact Person: Laura Hendricks
(916) 574-7918
This committee meeting is open to the public and is accessible to the physically disabled. A person who needs a disability-related accommodation or modification in order to participate in the meeting may make a request by contacting Laura Hendricks at (916) 574-7918, by emailing laura.hendricks@dca.ca.gov or sending a written request to Ms. Hendricks at the Board of Pharmacy, 1625 N. Market Blvd., Suite N-219, Sacramento, CA 95834. Providing your request at least five business days before the meeting will help to ensure availability of the requested accommodation.
DATE: March 19, 2013 PLACE: NOTE LOCATION: DCA Headquarters Building Two 1747 North Market Blvd Room 186 Sacramento, CA 95834 This meeting may be cancelled without notice. For verification of the meeting, call (916) 574-7900 or access the Board’s Web site at www.pharmacy.ca.gov. Discussion and action may be taken on any item on the agenda. The committee may discuss agenda items in any order. Time limitations for discussion and comment will be determined by the Committee Chair.
Agenda Call to Order 10 a.m. I. General Background of Compounding Pharmacies in California II. Discussion Regarding California’s Amended Compounding Regulations to Take Effect April 1, 2013 – Amendments to 16 California Code of Regulations, Sections 1735.1, 1735.2 and 1751.2 III. Discussion Regarding the Introduction of the Board of Pharmacy’s Sponsored Legislation on Sterile Compounding, Senate Bill 294 (Emmerson) IV. Discussion Regarding USP’s 797 Standards and Regulation Requirements of the Board of Pharmacy
V. Discussion Regarding “Batches” VI. Discussion of the Board of Pharmacy’s Questions and Answers Document on Compounding VII. General Discussion VIII. Closing Comments X. Public Comment on Items Not on the Agenda/Agenda Items For Future Meetings
Note: The committee may not discuss or take action on any matter raised during this public comment section that is not included on this agenda, except to decide whether to place the matter on the agenda of a future meeting. [Government Code Sections 11125, 11125.7(a)] ADJOURNMENT 4 p.m.
California State Board of Pharmacy – Compounding Subcommittee Meeting – March 19, 2013 Page 2 of 2 1625 N. Market Blvd, N219, Sacramento, CA 95834 Phone: (916) 574-7900 Fax: (916) 574-8618 www.pharmacy.ca.gov
STATE AND CONSUMER SERVICES AGENCY
DEPARTMENT OF CONSUMER AFFAIRS
GOVERNOR EDMUND G. BROWN JR.
Page 1 of 2 Meeting Materials will be available on the board’s Web site at www.pharmacy.ca.gov by March 18, 2013
NOTICE OF MEETING AND AGENDA
Compounding Subcommittee
March 19, 2013
Contact Person: Laura Hendricks
(916) 574-7918
This committee meeting is open to the public and is accessible to the physically disabled. A person who needs a disability-related accommodation or modification in order to participate in the meeting may make a request by contacting Laura Hendricks at (916) 574-7918, by emailing laura.hendricks@dca.ca.gov or sending a written request to Ms. Hendricks at the Board of Pharmacy, 1625 N. Market Blvd., Suite N-219, Sacramento, CA 95834. Providing your request at least five business days before the meeting will help to ensure availability of the requested accommodation.
DATE: March 19, 2013 PLACE: NOTE LOCATION: DCA Headquarters Building Two 1747 North Market Blvd Room 186 Sacramento, CA 95834 This meeting may be cancelled without notice. For verification of the meeting, call (916) 574-7900 or access the Board’s Web site at www.pharmacy.ca.gov. Discussion and action may be taken on any item on the agenda. The committee may discuss agenda items in any order. Time limitations for discussion and comment will be determined by the Committee Chair.
Agenda Call to Order 10 a.m. I. General Background of Compounding Pharmacies in California II. Discussion Regarding California’s Amended Compounding Regulations to Take Effect April 1, 2013 – Amendments to 16 California Code of Regulations, Sections 1735.1, 1735.2 and 1751.2 III. Discussion Regarding the Introduction of the Board of Pharmacy’s Sponsored Legislation on Sterile Compounding, Senate Bill 294 (Emmerson) IV. Discussion Regarding USP’s 797 Standards and Regulation Requirements of the Board of Pharmacy
V. Discussion Regarding “Batches” VI. Discussion of the Board of Pharmacy’s Questions and Answers Document on Compounding VII. General Discussion VIII. Closing Comments X. Public Comment on Items Not on the Agenda/Agenda Items For Future Meetings
Note: The committee may not discuss or take action on any matter raised during this public comment section that is not included on this agenda, except to decide whether to place the matter on the agenda of a future meeting. [Government Code Sections 11125, 11125.7(a)] ADJOURNMENT 4 p.m.
California State Board of Pharmacy – Compounding Subcommittee Meeting – March 19, 2013 Page 2 of 2
No comments:
Post a Comment